Fig. 6

Relationship between riskScore and clinical pathological characteristics of HCC. (A) Sankey diagram showing the proportion of high-risk and low-risk groups and TIDE immune response and patient survival and clinical stage. (B, D, F) The proportion of T stage, stage, and survival status between high-risk and low-risk groups. (C, E, G) Differences in riskScores of patients with different T and Stage, and differences in riskScores of patients who survive and die. (H, J) Analysis of differences in TMB and MaxVAF values of patients in high-risk and low-risk groups. (I, K) Correlation analysis between riskScore and TMB and MaxVAF values.